Epirubicin in malignant mesothelioma: A phase II study of The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Academic Article uri icon

Overview

MeSH Major

  • Epirubicin
  • Mesothelioma
  • Thoracic Neoplasms

abstract

  • We conclude that further testing of EPI in malignant mesothelioma is warranted.

publication date

  • January 1992

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.1992.10.5.824

PubMed ID

  • 1569454

Additional Document Info

start page

  • 824

end page

  • 8

volume

  • 10

number

  • 5